Sunmark and Generic Eye Drops Recalled for Manufacturing Deficiency
K.C. Pharmaceuticals is recalling 341,568 bottles of Sunmark and generic tetrahydrozoline eye drops due to manufacturing practice deficiencies. The recall affects multiple brands distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA classified this as a Class II recall due to manufacturing practice deficiencies that could affect product safety and quality. Although no illnesses or injuries have been reported, the CGMP deviation related to fill line documentation represents a risk-of-harm situation where manufacturing process integrity has been compromised.
Plain-English summary
K.C. Pharmaceuticals is recalling 341,568 bottles of Sunmark Eye Drops Original Formula (tetrahydrozoline HCl 0.05%, 0.5 FL OZ) and equivalent products distributed under multiple brand names nationwide, including DG Health, Publix, TopCare, GoodSense, Circle K, Lil' Drug Store, Rugby, Leader, CAREone, Good Neighbor Pharmacy, Walgreens, CVS Health, H-E-B, Meijer, and Best Choice.
The recall is due to good manufacturing practice (CGMP) deficiencies related to a lack of documentation of the fill line, which is essential to manufacturing process control and product quality assurance.
The affected lots are RG21F01, RG21F02, and RG21F03, all with an expiration date of June 30, 2023. Multiple UPCs and NDCs are affected across the various distributor and retailer versions of this product.
The recalled product
- Product
- SUNMARK EYE DROPS ORIGINAL FORMULA (TETRAHYDROZOLINE HCL)
- Brand
- SUNMARK EYE DROPS ORIGINAL FORMULA
- Manufacturer
- K.C. Pharmaceuticals, Inc
- Category
- Drug — Ophthalmic
- Affected units
- 341,568
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) RG21F01
- Exp: 6/30/2023
- b) RG21F01
- c) RG21F01
- d) RG21F01
- RG21F02
- Exp 6/30/2023
- e) RG21F02
- RG21F03
- f) RG21F02
- g) RG21F02
- h) RG21F02
- i) RG21F02
- j) RG21F02
- k) RG21F02
- l) RG21F02
- m) RG21F03
- n) RG21F03
- o) RG21F03
- p) RG21F03
UPCs (19)
- 0010939167330
- 0180410000156
- 0041250829164
- 095072005565
- 041415010765
- 010939167330
- 036800036390
- 180410000156
- 194283651858
- 366715683243
- 305361217945
- 096295136456
- 041520865311
- 087701149757
- 311917200767
- 050428361313
- 041220437474
- 041250829164
- 070038470113
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by K.C. Pharmaceuticals, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · SUNMARK EYE DROPS ORIGINAL FORMULA
- ModerateSunmark Eye Drops Recalled for Non-GMP API Storage
FDA (Drugs) · 2014-12-31
Same manufacturer · K.C. Pharmaceuticals, Inc
See all →- HighArtificial tears glycerin drops recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-08
- HighGNP redness and dry eye relief drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
- HighLeader ultra lubricating eye drops recalled over sterility assurance failure
FDA (Drugs) · 2026-04-08
- HighQuality Choice irritation relief eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
- HighRugby and Walgreens lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09